Catalog No.
YVV25304
Expression system
E. coli
Species
Dengue virus type 4 (strain Dominica/814669/1981) (DENV-4)
Protein length
Gly121-Arg204
Predicted molecular weight
37.81 kDa
Nature
Recombinant
Endotoxin level
Please contact with the lab for this information.
Purity
>90% as determined by SDS-PAGE.
Accession
P09866
Applications
ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Form
Lyophilized
Storage buffer
Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol.
Reconstitution
Reconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details.
Shipping
In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
Alternative Names
Genome polyprotein, Protein prM, Precursor membrane protein
Antiviral in vitro activity of a novel dichlorinated tyrosine methyl ester derivative against the infection of two flaviviruses of public health concern, dengue and zika virus., PMID:40450991
Development of New Live-Attenuated Vaccine Candidates Lacking Antibody-Dependent Enhancement (ADE) Against Dengue., PMID:40432141
Identification of Potential Inhibitors Targeting Non-Structural Proteins NS3 and NS5 of Dengue Virus Using Docking and Deep Learning Approaches., PMID:40284001
Integrated serological surveillance for neglected tropical diseases, vaccine-preventable diseases, and arboviruses in Samoa, 2018., PMID:40221582
Advancements in dengue vaccines: A historical overview and pro-spects for following next-generation candidates., PMID:40044132
Dengue dynamics in Bali: Serotype shifts, genotype replacement and multiple virus lineage circulation in the last 10 years., PMID:40008453
miRNome analysis reveals mir-155-5p as a protective factor to dengue infection in a resistant Thai cohort., PMID:39976655
Investigation of severe dengue outbreak in Maumere, East Nusa Tenggara, Indonesia: Clinical, serological, and virological features., PMID:39965014
RT-RPA Assisted CRISPR/Cas12a Based One-Pot Rapid and Visual Detection of the Pan-Dengue Virus., PMID:39949262
Comparison of clinical and virological features in pediatric and adult dengue cases at Insein General Hospital during Myanmar's 2022 dengue season., PMID:39881372
Achievements and Approaches in the Search for Small-Molecule Dengue NS2B/NS3 Inhibitors., PMID:39871573
Simultaneous detection of dengue virus serotypes in a dual-serotype-detection nucleic acid based lateral flow assay., PMID:39798241
Genetic diversity of dengue virus circulating in the Philippines (2014-2019) and comparison with dengue vaccine strains., PMID:39700304
Computational identification of Vernonia cinerea-derived phytochemicals as potential inhibitors of nonstructural protein 1 (NSP1) in dengue virus serotype-2., PMID:39474614
Efficacy and safety of Butantan-DV in participants aged 2-59 years through an extended follow-up: results from a double-blind, randomised, placebo-controlled, phase 3, multicentre trial in Brazil., PMID:39116904
Impact of pre-existing cross-reactive antibodies on cyclic dengue outbreaks in the hyperendemic region of Bali, Indonesia., PMID:39089369
Machine-learning-assisted high-throughput identification of potent and stable neutralizing antibodies against all four dengue virus serotypes., PMID:39060292
Circulating serotypes and genotypes of dengue virus in North India: An observational study., PMID:38648413
A 2D-proteomic analysis identifies proteins differentially regulated by two different dengue virus serotypes., PMID:38594317
E-Protein Protonation Titration-Induced Single-Particle Chemical Force Spectroscopy for Microscopic Understanding and pI Estimation of Infectious DENV., PMID:38512319
Characterization of Dengue Virus 4 Cases in Paraguay, 2019-2020., PMID:38399957
Non-structural protein 1 and hematology parameters as predictors of dengue virus infection severity in Indonesia., PMID:38313186
Live, Attenuated, Tetravalent Butantan-Dengue Vaccine in Children and Adults., PMID:38294972
Neutralizing antibodies from prior exposure to dengue virus negatively correlate with viremia on re-infection., PMID:37857747
Safety and durable immunogenicity of the TV005 tetravalent dengue vaccine, across serotypes and age groups, in dengue-endemic Bangladesh: a randomised, controlled trial., PMID:37776876
Resurgence of Dengue Virus Serotype 4 in Malaysia: A Comprehensive Clinicodemographic and Genomic Analysis., PMID:37624348
Serotype-associated immune response and network immunoclusters in children and adults during acute Dengue virus infection., PMID:37542834
A Phase 1, double-blind, randomized, placebo-controlled study to evaluate the safety and immunogenicity of a tetravalent live attenuated dengue vaccine in adults., PMID:37532611
Epitope prediction and designing of receptor inhibitor of Dengue Envelope Protein: An in silico approach., PMID:37417165
Experimental Dengue Virus Type 4 Infection Increases the Expression of MicroRNAs-15/16, Triggering a Caspase-Induced Apoptosis Pathway., PMID:37367040
Isolation and Genetic Evolution of Dengue Virus from the 2019 Outbreak in Xishuangbanna, Yunnan Province, China., PMID:37184906
Primary infection of BALB/c mice with a dengue virus type 4 strain leads to kidney injury., PMID:37162062
Intrahost Genetic Diversity of Dengue Virus in Human Hosts and Mosquito Vectors under Natural Conditions Which Impact Replicative Fitness In Vitro., PMID:37112962
Evolutionary dynamics of dengue virus in India., PMID:37011104
A Six Years (2010-2016) Longitudinal Survey of the Four Serotypes of Dengue Viruses in Lao PDR., PMID:36838207
Stability of Dengue 2 Nonstructural Glycoprotein 1 (NS1) Is Affected by the Nature of Basic Residue at Position NS1-324., PMID:36826051
Development of novel antiviral peptides against dengue serotypes 1-4., PMID:36739680
The dengue virus 4 component of NIAID's tetravalent TV003 vaccine drives its innate immune signature., PMID:36734144
Discrepant Activation Pattern of Inflammation and Pyroptosis Induced in Dermal Fibroblasts in Response to Dengue Virus Serotypes 1 and 2 and Nonstructural Protein 1., PMID:36629424
Performance of the onstructural 1 Antigen Rapid Test for detecting all four DENV serotypes in clinical specimens from Bangkok, Thailand., PMID:36303183
Assessment of Dengue and Chikungunya Infections among Febrile Patients Visiting Four Healthcare Centres in Yaoundé and Dizangué, Cameroon., PMID:36298682
Epidemiology of dengue in SAARC territory: a systematic review and meta-analysis., PMID:36280877
Genetic characterization of dengue virus 4 complete genomes from East Java, Indonesia., PMID:36266496
Incidence of Dengue fever, serotypes, clinical features, and laboratory markers: a case study of 2019 outbreak at district Shangla, KP, Pakistan., PMID:36032477
Genetic diversity and spatiotemporal dynamics of DENV-1 and DENV-2 infections during the 2012-2013 outbreak in Mexico., PMID:35779336
Epidemiological and hematological investigation of dengue virus infection., PMID:35769047
Construction of a Dengue NanoLuc Reporter Virus for In Vivo Live Imaging in Mice., PMID:35746724
Molecular Characterization and Identification of Potential Inhibitors for 'E' Protein of Dengue Virus., PMID:35632682
Acute-phase Serum Cytokine Levels and Correlation with Clinical Outcomes in Children and Adults with Primary and Secondary Dengue Virus Infection in Myanmar between 2017 and 2019., PMID:35631079
Seroepidemiologic study on convalescent sera from dengue fever patients in Jinghong, Yunnan., PMID:35234619
For research use only. Not for human or drug use.
